Progesterone Hypersensitivity in Assisted Reproductive Technologies: Implications for Safety and Efficacy

Area of Science:

• Reproductive Medicine
• Dermatology
• Immunology

Background:

• Global rise in childbirth age and increased prevalence of assisted reproductive techniques (ARTs).
• Autoimmune progesterone dermatitis (APD), or progesterone hypersensitivity, is a mucocutaneous syndrome triggered by progesterone.
• APD commonly presents with dermatological symptoms and can lead to systemic reactions, posing challenges for women of childbearing age.

Purpose of the Study:

• To explore the link between the rise in ARTs and the increasing incidence of iatrogenic autoimmune progesterone dermatitis (APD).
• To investigate the heightened risk of secondary APD in patients undergoing ART due to exogenous progesterone administration.
• To review therapeutic interventions for managing APD in women undergoing ART to achieve successful pregnancies.

Main Methods:

• Review of literature on ART, APD, and progesterone hypersensitivity.
• Analysis of clinical data linking exogenous progesterone administration via intramuscular, intravaginal, and oral routes to secondary APD in ART patients.
• Exploration of current therapeutic strategies for managing APD during ART.

Main Results:

• Findings indicate a significantly higher likelihood of developing secondary APD in patients undergoing ART.
• Exogenous progesterone administration through various routes (intramuscular, intravaginal, oral) is identified as a key factor.
• The study highlights the challenges APD presents to fertility treatments and pregnancy outcomes.

Conclusions:

• ARTs are associated with an increased risk of iatrogenic autoimmune progesterone dermatitis.
• Management strategies are crucial for successful pregnancies in ART patients with APD.
• Further research into the mechanisms and treatments of APD in the context of ART is warranted.